Cross-linking agents of collagen fibers for the use in the treatment of corneal ectasia
US10688196B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2015 |
| Grant date | Jun 23, 2020 |
| Priority date | — |
| Expiry date | Apr 29, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It is described a complex of riboflavin into hydroxypropylated β-cyclodextrins as photosensitizer in the riboflavin-UV mediated cross-linking of corneal collage fibers and the relative ophthalmic compositions comprising it.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.